PharmaRoth Labs (PharmaRoth Labs) Other Net Income (Loss) : $-0.59 Mil (TTM As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Other Net Income (Loss)?

PharmaRoth Labs's Other Net Income (Loss) for the three months ended in Mar. 2011 was $-0.10 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2011 was $-0.59 Mil.

PharmaRoth Labs's quarterly Other Net Income (Loss) increased from Sep. 2010 ($-0.22 Mil) to Dec. 2010 ($-0.02 Mil) but then declined from Dec. 2010 ($-0.02 Mil) to Mar. 2011 ($-0.10 Mil).

PharmaRoth Labs's annual Other Net Income (Loss) increased from Jun. 2008 ($-0.04 Mil) to Jun. 2009 ($-0.01 Mil) but then declined from Jun. 2009 ($-0.01 Mil) to Jun. 2010 ($-0.27 Mil).

PharmaRoth Labs Other Net Income (Loss) Historical Data

The historical data trend for PharmaRoth Labs's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Other Net Income (Loss) Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

Other Net Income (Loss)

-0.04

-0.01

-0.27

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Other Net Income (Loss)	Get a 7-Day Free Trial											-	-0.26	-0.22	-0.02	-0.10

PharmaRoth Labs Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.59 Mil.

PharmaRoth Labs Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022